Authors
W G Cao, Z L Yang
Published in
Zhonghua yi xue za zhi. Volume 106. Issue 40. Pages 4415-4419. Nov 03, 2026.
Abstract
Objective: To evaluate the safety and therapeutic efficacy local flap reconstruction for skin defects following surgery for Stage ⅢB breast cancer. Methods: A retrospective analysis was conducted on 42 patients with Stage ⅢB cancer admitted between January 2018 and December 2023. Among them, 24 patients underwent Auchincloss procedure combined with Stage local flap reconstruction, while 18 patients received neoadjuvant therapy without surgical intervention. Data recorded included operative time, intraoperative blood loss, hospital stay duration, defect reconstruction methods, and flap survival rates. 3-year overall survival rate and local recurrence-free survival rate were observed in both groups. Results: The neoad therapy efficacy rate for both groups was 80.95%(34/42), consisting of a complete response rate of 7.14%(3/42) and a partial response rate of 73.81%(31/42). The follow-up time [M (Q1, Q3)] was 39 (24, 61) months, with a of 5 deaths. Average operative time was 3.1 h (range: 2.5-5.1 h), the mean intraoperative blood loss was 310.0 ml (range: 243.3-392.0 ml), and the mean hospital stay was 11.2 d (range 9.5-17.1 d). The average soft tissue defect area was 13.5 cm×24.2 cm (range 12.0 cm×15.0 cm to 18.0 cm×26.0 cm). Reconstruction methods included direct suturing a modified ZipLine adhesive skin stretcher in 2 cases (8.3%), rectangular flap reconstruction in 6 cases (25.0%), rotation flap reconstruction in 9 cases (37.5%), and latissimus dorsi KISS flap reconstruction in 7 cases (29.2%). Flaps healed in Stage Ⅰ in 23 patients (95.8%); 1 patient (4.2%) experienced flap ischemia, which subsequently healed following intravenous vasodilator therapy. The 3-year overall survival rates for patients in the surgical group and the conservative treatment group were 91.67%(22/24) and 83.33%(15/24), respectively, with no statistically significant difference (log-rank P=0.321); the 3-year local recurrence-free survival for the surgical group and the conservative treatment group were 95.83%(23/24) and 66.67%(12/18), respectively (log-rank P=0.012). Conclusion: The Auchincloss procedure combined with Ⅰ local flap transfer for the repair of massive skin defects following neoadjuvant therapy for Stage ⅢB breast cancer is feasible.
PMID:
42967655
Bibliographic data and abstract were imported from PubMed on 02 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 18
- Comments 0